Dux Healthcare
AI system for Prediction of Epileptic Seizures
Company Overview
Snapshot
Founded in September 2024 by Noam Keidar, Dux Healthcare operates with 1–10 employees. The company has raised $165,000 across one funding round from Fusion VC. In January 2025, Dux Healthcare secured pre-seed funding, signaling early investor confidence in its innovative approach to healthcare technology.
Business overview
Dux Healthcare develops real-time healthcare solutions, focusing on guiding health at critical junctures. The company's core product is an AI system designed to predict epileptic seizures using consumer wearable EEG devices. This technology aims to forecast seizures 30 to 60 minutes in advance, enabling preventive measures, optimized use of abortive medications, and enhanced confidence for individuals during seizure-free periods. Dux Healthcare operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare, Digital Therapeutics, and Patient Engagement, serving patients and the broader healthcare and medical devices industries.
Log in to access full profile ›Company Intelligence Q&A
- What is Dux Healthcare's primary product?
- Dux Healthcare's primary product is a real-time AI system that predicts epileptic seizures using consumer wearable EEG devices. This technology aims to forecast seizures 30 to 60 minutes in advance.
- When was Dux Healthcare founded?
- Dux Healthcare was founded in September 2024.
- How many employees does Dux Healthcare currently have?
- Dux Healthcare currently has 1–10 employees.
- What is the total capital raised by Dux Healthcare?
- Dux Healthcare has raised a total of $165,000 across one funding round.
- Which investor participated in Dux Healthcare's funding round?
- Dux Healthcare received $165,000 in funding from Fusion VC in its Pre-Seed round.